跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DARUPH 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DARUPH 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
DARUPH 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Zentiva K.S.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 28, 2024
Approval ID
71ee199fb9682e85
Company
Zentiva K.S.
Type
Standard
Approval Details
Approval Id
71ee199fb9682e85
Drug Cima Aemps Name
DARUPH 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
89523
Holder Company Name
Zentiva K.S.
Marketing Company Name
Zentiva Spain S.L.
Holder Company Detail Path
/organization/zentiva-k-s
Authorization Date
2024-06-28
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
40 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Zentiva K.S.
Company Detail Path
/organization/zentiva-k-s
Company Information
Pharmaceutical Company Name
Zentiva, k.s.
Country Name
Czech Republic
City Name
praha,hlavní město praha,country_cz
Address
U kabelovny 130/22
Active Ingredients
DASATINIB
39,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 28, 2024
Approval ID
71ee199fb9682e85
Type
Standard
Back to CIMA-AEMPS Approvals
